GO
Loading...

Cramer Chats With Alkermes CEO Richard Pops

Although there is some downside risk, young companies with big ideas can deliver big returns, said Jim Cramer on CNBC's "Mad Money." There is probably no better place to look for these companies than in biotechnology sector, he continued, citing Alkermes as an example of an interesting speculative stock.

Based in Dublin, Alkermes develops drugs that primarily address disorders pertaining to the central nervous system, such as addiction, schizophrenia and depression. Cramer wanted to learn more about the company and its future prospects, so he welcomed CEO Richard Pops onto Thursday's program.

Watch the video to see the complete conversation!




Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
ALKS
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Cramer's New Book